IMAPAC Event» Business Conferences » Biologics World Korea 2013: The ONLY and MOST targeted biologics and biosimilars focused platform in Korea!
TARGET YOUR
MARKET NOW!

Contact
Neville De Nazareth
 

 

Biologics World Korea has attracted over 130 biologics industry leaders in 2012, it has established itself as the ONLY and MOST targeted biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.

Biologics World Korea 2013 brings you:

  • The most targeted platform to meet Korean and international biosimilars and biologics manufacturers
  • Unparalleled opportunities to network with Korea's biologic industry leaders face to face
  • Strategic discussions and debates with senior level decision makers who will influence the direction of Korea's biologics industry
  • First hand information on Korea's biologics industry regulatory system update
  • Real life case studies and innovative product showcase of some Korean's most innovative companies

Brochure Download

Biologics World Korea 2013 featured in The Korea Herald, 5 November 2012!

The Korea Herald

SIGN UP NOW for the
Complimentary Technical Workshops by Agilent, Ab Sciex and TAP Biosystems.

Date: 17 & 18 April 2013 | Time: 12:30 pm

 

Conference Chairman - Day 1

Dr. Byeong Doo Song, 
President,
Scripps Korea Antibody Institute, Korea

Conference Chairman - Day 2

Dr. Chong-Hwan Jonathan Chang,  
President, 
New Drug Development Center (NDDC)

2013 Featured Speakers

Dr. Sung Joo Lee,
Acting Head of AP Research Therapeutic Strategic Unit,
Asia Pacific R&D, Sanofi

Dr. Stanley Hong,
President, 
Celltrion, Korea

Dr. Paul Coleman,
Chief Executive Officer,
Hanhwa Biologics, Korea

Dr. Sehwan Yang,
Managing Director & Head of Research Institute,
Genexine, Korea

 

-> I want to attend as a delegate

-> I want to attend as a speaker

-> I want to suggest a topic

Sales and Marketing Opportunities at Biologics World Korea 2013 

Following the resounding success of the 2012 event, Biologics World Korea 2013 promises to be bigger and better industry convention attended by decision makers from leading biologics manufacturers from Korea and globally. It's your one stop solution to reach out to Korea's biologics industry!

However, to ensure quality and unbiased content of the programme, only very limited speaking opportunities are open to technology and solution providers. To ensure your target audience in Korea get to hear your product philosophy and successful case studies at the conference, it's important to discuss with us about your potential involvement early! Get involved by taking your first step, contact Neville De Nazareth at neville.nazareth@imapac.com or +65 6493 1598.
 

 
Distinguished Speaker Faculty Includes: 

Dr. Stanley Hong,
President, 
Celltrion, Korea

Dr. Paul Coleman,
Chief Executive Officer, 
Hanwha Biologics, Korea 
Dr. Sehwan Yang,
Managing Director & Head of Research Institute,
Genexine, Korea 

Dr. Hun-Taek Kim,
Vice President/Director,
Life Science R&D Center, SK Chemicals, Korea

Dr. Jin-San Yoo
President & CEO,
PharmAbcine, Korea 
Dr. Se-Ho Kim
Director of Antibody Engineering Unit,
Mogam Biotechnology Research Institute/Green Cross Corp, Korea 
Yariv Hefez,
Vice President, 
Merck Serono
Dr. Greg Elson,
Head of Manufacturing,
NovImmune, Switzerland.
Dr. Sungyoo Cho
Scientist, Bio-Pharm Center,
CJ Cheiljedang Corporation, Korea

Dr. Young Woo Park
Principal Research Scientist,
KRIBB, Korea

Dr. Gyun Min Lee,
Professor,
Department of Biological Sciences, KAIST, Korea
Dr. Jong Shin Yoo,
Vice President,
Korea Basic Science Institute, Korea

Dr. Madi R. Madiyalakan,
Chief Executive Officer,
Quest PharmaTech Inc.

Dr. Yong-Soo Bae,
Chief Executive Officer,
Creagene, 
Professor
Department of Biological Science, Sungkyunwan University
Tom Roberts,
Managing Director, 
UCB Korea, Ltd. 

Dr. George Wang,
Executive Director of Analytical & Bioanalytical Servcies, 
Wuxi Apptec Co. Ltd, China

Dr. Elizabeth S. Song,
Consultant, 
Neopharm Co., Ltd., Korea
Dr. Doo Hyun Kim,
CTO, SVP of Bioprocessing, 
Binex Co. Ltd, Korea


Dr. Grace Wong
CEO, 
ActoKine Therapeutics, USA 

Professor Hong Hyo-Jung,
Professor,
Kanwong University, Korea 
Michael Yu
President and Chief Executive Officer, 
Innovent Biologics


Dr. Karen Wen
President, 
Mycenax Biotech Inc., Taiwan 

Dr. Daniel Adams
Executive Chairman, 
Protein Sciences Corporation, USA

Huyn Joo An,
Associate Professor, Graduate School of Analytical and Science Technology,
Chungnam National University, Korea





Dennis Chan
Former Director, Ministry of Health, Canada 


Dr. Sung Joo Lee,
Acting Head of AP Research Therapeutic Strategic Unit,
Asia Pacific R&D, Sanofi

 

Nicolas Havelange,  Business Development,
Cell Culture Technologies,
ATMI LifeSciences



 
Event Sponsors 2013
Gold Sponsor
BD Biosciences
Session Sponsor
Associate Sponsors
 
Exhibitors
 
 

Supporting Organization


 

Sponsorship

 
Media Partners
BioSpectrum Asia
If you are interested to become our media partner or endorsing association, please contact
Natasha Jiandani